Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongfei Wang

Showing results (261-270 of 298) with videos related to

Pageof 30
Sort By:
Cancer Biology & Therapy|September 17, 2024
EX527, a sirtuins 1 inhibitor, sensitizes T-cell leukemia to death receptor-mediated apoptosis by downregulating cellular FLICE inhibitory proteinRongqi Guo, Yihui Wei, Yating Du, et al.
Materials Today. Bio|June 9, 2025
Enhancing tumor immunotherapy with smart nanoparticles for reprogramming macrophages and blocking the CD47/Sirpα pathwayZubair Hussain, Shanshan Gou, Xu Liu, et al.
Theranostics|June 23, 2021
Adjuvant-free peptide vaccine targeting Clec9a on dendritic cells can induce robust antitumor immune response through Syk/IL-21 axisShanshan Gou, Shuai Wang, Wenwen Liu, et al.
International Journal of Biological Macromolecules|December 11, 2025
Zein-lecithin core-shell nanoparticles for andrographolide delivery to synergistically enhance anti-inflammatory and antioxidant activities in RAW264.7 cellsXiaolu Hua, Enhui Zheng, HongFei Wang, et al.
Cell Communication and Signaling : CCS|September 7, 2020
Repositioning liothyronine for cancer immunotherapy by blocking the interaction of immune checkpoint TIGIT/PVRXiuman Zhou, Jiangfeng Du, Hongfei Wang, et al.
Cancer Letters|April 15, 2019
Combined class I histone deacetylase and mTORC1/C2 inhibition suppresses the initiation and recurrence of oral squamous cell carcinomas by repressing SOX2Xueyi Liang, Miao Deng, Chi Zhang, et al.
Biomolecules|June 2, 2021
Repositioning Azelnidipine as a Dual Inhibitor Targeting CD47/SIRPα and TIGIT/PVR Pathways for Cancer Immuno-TherapyXiuman Zhou, Ling Jiao, Yuzhen Qian, et al.
The Journal of Bone and Joint Surgery. American Volume|February 1, 2023
Neurological Survivorship Following Surgery for Degenerative Cervical Myelopathy: A Longitudinal Study on 195 PatientsVictor Hin Ting Yick, Changmeng Zhang, Janus Siu Him Wong, et al.
Angewandte Chemie (International Ed. in English)|June 24, 2025
Stepwise Post-Modification of Pyridine-Imine COFs for Enhanced Hydrolytic Stability and Proton ConductivityHongfei Wang, Wen-Na Jiao, Wei-De Zhu, et al.
Medcomm|June 28, 2024
Associations of blood pressure in the third trimester and risk of venous thromboembolism postpartumQian Li, Hongfei Wang, Huafang Wang, et al.
Pageof 30

Showing results (261-270 of 298) with videos related to

Sort By:
Pageof 30
Cancer Biology & Therapy|September 17, 2024
EX527, a sirtuins 1 inhibitor, sensitizes T-cell leukemia to death receptor-mediated apoptosis by downregulating cellular FLICE inhibitory proteinRongqi Guo, Yihui Wei, Yating Du, et al.
Materials Today. Bio|June 9, 2025
Enhancing tumor immunotherapy with smart nanoparticles for reprogramming macrophages and blocking the CD47/Sirpα pathwayZubair Hussain, Shanshan Gou, Xu Liu, et al.
Theranostics|June 23, 2021
Adjuvant-free peptide vaccine targeting Clec9a on dendritic cells can induce robust antitumor immune response through Syk/IL-21 axisShanshan Gou, Shuai Wang, Wenwen Liu, et al.
International Journal of Biological Macromolecules|December 11, 2025
Zein-lecithin core-shell nanoparticles for andrographolide delivery to synergistically enhance anti-inflammatory and antioxidant activities in RAW264.7 cellsXiaolu Hua, Enhui Zheng, HongFei Wang, et al.
Cell Communication and Signaling : CCS|September 7, 2020
Repositioning liothyronine for cancer immunotherapy by blocking the interaction of immune checkpoint TIGIT/PVRXiuman Zhou, Jiangfeng Du, Hongfei Wang, et al.
Cancer Letters|April 15, 2019
Combined class I histone deacetylase and mTORC1/C2 inhibition suppresses the initiation and recurrence of oral squamous cell carcinomas by repressing SOX2Xueyi Liang, Miao Deng, Chi Zhang, et al.
Biomolecules|June 2, 2021
Repositioning Azelnidipine as a Dual Inhibitor Targeting CD47/SIRPα and TIGIT/PVR Pathways for Cancer Immuno-TherapyXiuman Zhou, Ling Jiao, Yuzhen Qian, et al.
The Journal of Bone and Joint Surgery. American Volume|February 1, 2023
Neurological Survivorship Following Surgery for Degenerative Cervical Myelopathy: A Longitudinal Study on 195 PatientsVictor Hin Ting Yick, Changmeng Zhang, Janus Siu Him Wong, et al.
Angewandte Chemie (International Ed. in English)|June 24, 2025
Stepwise Post-Modification of Pyridine-Imine COFs for Enhanced Hydrolytic Stability and Proton ConductivityHongfei Wang, Wen-Na Jiao, Wei-De Zhu, et al.
Medcomm|June 28, 2024
Associations of blood pressure in the third trimester and risk of venous thromboembolism postpartumQian Li, Hongfei Wang, Huafang Wang, et al.
Pageof 30